# Project Handoff: TP53 Structural Variance Engine (TP53-SVE)

This handoff summary captures the current, finalized state of the TP53-SVE project, transitioned from Fisher's LDA to the high-performance Kolmogorov-Arnold Network (KAN) architecture.

---

## 1. Project Overview & Core Tech
The TP53-SVE is an end-to-end pipeline for structural diagnosis, clinical explainability, and mRNA vaccine design for cancer-associated TP53 mutations.

### Key Components:
1.  **Ensemble Folding:** AlphaFold 3 (Wild-Type) ensemble-averaged with ESMFold (128 Mutations) to calculate high-fidelity 3D structural shifts.
2.  **SVE Feature Engine:** A 34-dimensional biophysical suite (RMSD, TM-Score, DBCA, ARES, pLDDT-drops, SASA-exposure, Contact Loss, etc.).
3.  **KAN Diagnostic Model:** A Kolmogorov-Arnold Network using learnable B-splines. Accuracy: **88.2% (LOOCV)**.
4.  **XAI & Clinical Rescue:** SHAP (feature importance) and Counterfactual Gradient Descent for identifying "minimal structural intervention" drug targets.
5.  **Autonomous Bio-Compiler:** Local LLM integration (via **LM Studio / Qwen3.5-9B**) for codon optimization and mechanistic structural reports.

---

## 2. Infrastructure & Workspace Requirements
To continue the project in a new workspace, ensure the following are configured:

### Environment:
- **Python:** 3.11+
- **Libraries:** `pykan` or `efficient-kan`, `torch`, `streamlit`, `openai`, `pandas`, `biopython`, `prody`, `plotly`.
- **Local LLM:** LM Studio running a server at `http://127.0.0.1:1234/v1` with a model like `qwen/qwen3.5-9b`.

### Key Paths:
- **Main App:** `antigravity_webapp.py` (The Streamlit Dashboard).
- **Core Engine:** `src/phase3/tp53_sve.py` (Feature extraction and KAN inference).
- **XAI Engine:** `src/phase3/kan_counterfactual.py` and `src/phase3/kan_shap_explainer.py`.
- **Vaccine Engine:** `src/phase4_true_vaccine_pipeline.py`.

---

## 3. Current Project State: COMPLETE
- [x] **Phase 1-2:** Structural simulation and 34-feature extraction complete (128 variants).
- [x] **Phase 3:** KAN model trained and validated (LOOCV 88%).
- [x] **Phase 4:** SHAP values and Counterfactual rescue gradients fully implemented.
- [x] **Phase 5:** mRNA Bio-Compiler with Local LLM (LM Studio) integration successful.
- [x] **Presentation:** Premium Streamlit dashboard deployed with XAI tabs and live LLM reporting.
- [x] **Documentation:** 12-page Technical Report and Premium Architecture HTML generated.

---

## 4. Next Steps for Development
1.  **Multi-Protein Expansion:** Apply the SVE pipeline to KRAS, BRCA1, or EGFR.
2.  **Drug Docking:** Integrate an automated docking script (e.g., AutoDock Vina) to validate counterfactual rescue sites.
3.  **Real-Time AF3:** Upgrade mutant folding from ESMFold to a direct AF3 server connection for atomic precision.

---
**Handoff Complete.** Ready to synthesize.
